TenAces Biosciences
PrivateLast Round
Seed
Jan 30, 2024
Company Overview
TenAces Biosciences operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Seed round in January 2024.
TenAces Biosciences is a biotechnology company that leverages machine learning and data-centric approaches to discover and develop molecular glue therapeutics for targeted protein degradation.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TenAces Biosciences Comparables
Compare TenAces Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ternary Therapeutics | 95% | |
| GluBio Therapeutics | 86% | |
| Degron Therapeutics | 84% |
For institutional investors. Book with your work email.
TenAces Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
TenAces Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | Seed |
| Amiti Ventures | Seed |
| Pfizer | Seed |
| AION Labs | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2024
Seed round included investors Pfizer, Amiti Ventures, and Israel Biotech Fund.
For institutional investors. Book with your work email.
TenAces Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TenAces Biosciences's valuation, stock price, and market status.
Is TenAces Biosciences a public or private company?
TenAces Biosciences is a private company.
What is the current stock price of TenAces Biosciences?
TenAces Biosciences is a private company, so its shares have no public market price. Caplight tracks TenAces Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TenAces Biosciences worth (valuation)?
Valuation information for TenAces Biosciences is not publicly available.
Can I buy TenAces Biosciences stock?
TenAces Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TenAces Biosciences's last funding round?
TenAces Biosciences's most recent funding round was Seed on January 30, 2024.
Who are the main investors in TenAces Biosciences?
Key investors in TenAces Biosciences include Israel Biotech Fund, Amiti Ventures, Pfizer, AION Labs.
Will TenAces Biosciences IPO soon?
No public IPO plans have been announced for TenAces Biosciences.
How can I track TenAces Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in TenAces Biosciences's shares on secondary markets.